Treatment-naïve subgroup (N=55) | |||||
Visits | Mean (SD) IOP, mm Hg | IOP ≥21 mm Hg, n (%) | IOP increase ≥10 mm Hg, n (%) | IOP increase ≥25 mm Hg, n (%) | Patients who required 1/2/≥3 IOP-lowering medications, n (%) |
Baseline | 14.0 (3.7) | 2 (3.7) | 0 | 0 | 5 (9.3)/1 (1.9)/6 (11.1) |
N | 54 | 54 | 54 | 54 | 54 |
Week 6 | 17.9 (7.7) | 11 (23.9) | 6 (13.0) | 0 | 3 (6.5)/1 (2.2)/6 (13.0) |
N | 46 | 46 | 46 | 46 | 46 |
Week 16 | 14.8 (3.7) | 4 (8.2) | 1 (2.0) | 0 | 4 (8.2)/1 (2.0)/5 (10.2) |
N | 49 | 49 | 49 | 49 | 49 |
Week 24 | 16.0 (6.3) | 4 (12.5) | 3 (9.4) | 0 | 3 (9.4)/1 (3.1)/3 (9.4) |
N | 32 | 32 | 32 | 32 | 32 |
Week 52 | 16.0 (4.9) | 6 (15.0) | 4 (10.0) | 0 | 4 (10.0)/1 (2.5)/3 (7.5) |
N | 40 | 40 | 40 | 40 | 40 |
IOP, intraocular pressure.